Insider Trading Alert - WBC, SCSC And CNMD Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Friday, May 8, 2015, 68 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,023.75 to $5,610,306.91.

Highlighted Stocks Traded by Insiders:

Wabco Holdings (WBC) - FREE Research Report

Varty Nikhil M, who is President, Americas & VP, M&A at Wabco Holdings, sold 1,410 shares at $124.86 on May 8, 2015. Following this transaction, the President, Americas & VP, M&A owned 10,815 shares meaning that the stake was reduced by 11.53% with the 1,410-share transaction.

The shares most recently traded at $126.55, up $1.69, or 1.34% since the insider transaction. Historical insider transactions for Wabco Holdings go as follows:

  • 4-Week # shares sold: 2,971
  • 12-Week # shares sold: 5,145
  • 24-Week # shares sold: 5,145

The average volume for Wabco Holdings has been 603,100 shares per day over the past 30 days. Wabco Holdings has a market cap of $7.3 billion and is part of the consumer goods sector and automotive industry. Shares are up 19.56% year-to-date as of the close of trading on Friday.

WABCO Holdings Inc., together with its subsidiaries, provides electronic, mechanical, and mechatronic products for commercial truck, trailer, bus, and passenger car manufacturers worldwide. The company has a P/E ratio of 25.5. Currently, there are 7 analysts who rate Wabco Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WBC - FREE

TheStreet Quant Ratings rates Wabco Holdings as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Wabco Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

ScanSource (SCSC) - FREE Research Report

Fischer Steven R, who is Director at ScanSource, sold 9,400 shares at $39.05 on May 8, 2015. Following this transaction, the Director owned 28,267 shares meaning that the stake was reduced by 24.96% with the 9,400-share transaction.

The shares most recently traded at $39.50, up $0.45, or 1.14% since the insider transaction. Historical insider transactions for ScanSource go as follows:

  • 4-Week # shares bought: 2,200
  • 4-Week # shares sold: 20,000
  • 12-Week # shares bought: 2,200
  • 12-Week # shares sold: 21,000
  • 24-Week # shares bought: 2,200
  • 24-Week # shares sold: 40,209

The average volume for ScanSource has been 102,500 shares per day over the past 30 days. ScanSource has a market cap of $1.1 billion and is part of the technology sector and computer software & services industry. Shares are down 1.57% year-to-date as of the close of trading on Friday.

ScanSource, Inc. operates as a wholesale distributor of specialty technology products in North America and internationally. It operates in two segments, Worldwide Barcode & Security and Worldwide Communications & Services. The company has a P/E ratio of 15.0. Currently, there is 1 analyst who rates ScanSource a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SCSC - FREE

TheStreet Quant Ratings rates ScanSource as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, increase in stock price during the past year and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full ScanSource Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Conmed (CNMD) - FREE Research Report

Beyer Pat, who is President-Conmed International at Conmed, bought 5,000 shares at $53.36 on May 8, 2015. Following this transaction, the President-Conmed International owned 5,000 shares meaning that the stake was boosted by 100% with the 5,000-share transaction.

The shares most recently traded at $55.36, up $2.00, or 3.61% since the insider transaction. Historical insider transactions for Conmed go as follows:

  • 4-Week # shares bought: 235
  • 4-Week # shares sold: 8,399
  • 12-Week # shares bought: 235
  • 12-Week # shares sold: 8,399
  • 24-Week # shares bought: 235
  • 24-Week # shares sold: 9,399

The average volume for Conmed has been 152,900 shares per day over the past 30 days. Conmed has a market cap of $1.5 billion and is part of the health care sector and health services industry. Shares are up 19.08% year-to-date as of the close of trading on Friday.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures and monitoring in the United States, Canada, the United Kingdom, Japan, Australia, and internationally. The stock currently has a dividend yield of 1.49%. The company has a P/E ratio of 49.6. Currently, there are 3 analysts who rate Conmed a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CNMD - FREE

TheStreet Quant Ratings rates Conmed as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Conmed Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

Dow Posts First Gain in Nine Sessions; Oil Jumps

Dow Posts First Gain in Nine Sessions; Oil Jumps